Literature DB >> 18579380

Autosomal dominant congenital spinal muscular atrophy--a possible developmental deficiency of motor neurones?

S Reddel1, R A Ouvrier, G Nicholson, I Dierick, J Irobi, V Timmerman, M M Ryan.   

Abstract

We describe a kindred with an unusual congenital lower motor neuron disorder with significant but static muscle weakness predominantly affecting the lower limbs. The proband had talipes equinovarus and congenital hip contractures and did not walk until 19 months of age. Lower-extremity predominant, primarily proximal weakness was identified on assessment at three years. Over a 20 year follow-up there has been no clinical progression. The proband has a four-year-old daughter with very similar clinical findings. Electromyography and muscle biopsy suggest reduced numbers of giant normal duration motor units with little evidence of denervation or reinnervation. Dominant congenital spinal muscular atrophy predominantly affecting the lower limbs is rarely described. It is possible that the disorder is due to a congenital deficiency of motor neurons.

Entities:  

Mesh:

Year:  2008        PMID: 18579380     DOI: 10.1016/j.nmd.2008.04.016

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  5 in total

1.  Molecular defects in the motor adaptor BICD2 cause proximal spinal muscular atrophy with autosomal-dominant inheritance.

Authors:  Kristien Peeters; Ivan Litvinenko; Bob Asselbergh; Leonardo Almeida-Souza; Teodora Chamova; Thomas Geuens; Elke Ydens; Magdalena Zimoń; Joy Irobi; Els De Vriendt; Vicky De Winter; Tinne Ooms; Vincent Timmerman; Ivailo Tournev; Albena Jordanova
Journal:  Am J Hum Genet       Date:  2013-05-09       Impact factor: 11.025

2.  Dominant spinal muscular atrophy with lower extremity predominance: linkage to 14q32.

Authors:  M B Harms; P Allred; R Gardner; J A Fernandes Filho; J Florence; A Pestronk; M Al-Lozi; R H Baloh
Journal:  Neurology       Date:  2010-08-10       Impact factor: 9.910

3.  Phenotypic and molecular insights into spinal muscular atrophy due to mutations in BICD2.

Authors:  Alexander M Rossor; Emily C Oates; Hannah K Salter; Yang Liu; Sinead M Murphy; Rebecca Schule; Michael A Gonzalez; Mariacristina Scoto; Rahul Phadke; Caroline A Sewry; Henry Houlden; Albena Jordanova; Iyailo Tournev; Teodora Chamova; Ivan Litvinenko; Stephan Zuchner; David N Herrmann; Julian Blake; Janet E Sowden; Gyuda Acsadi; Michael L Rodriguez; Manoj P Menezes; Nigel F Clarke; Michaela Auer Grumbach; Simon L Bullock; Francesco Muntoni; Mary M Reilly; Kathryn N North
Journal:  Brain       Date:  2014-12-14       Impact factor: 13.501

4.  Novel mutations expand the clinical spectrum of DYNC1H1-associated spinal muscular atrophy.

Authors:  Mariacristina Scoto; Alexander M Rossor; Matthew B Harms; Sebahattin Cirak; Mattia Calissano; Stephanie Robb; Adnan Y Manzur; Amaia Martínez Arroyo; Aida Rodriguez Sanz; Sahar Mansour; Penny Fallon; Irene Hadjikoumi; Andrea Klein; Michele Yang; Marianne De Visser; W C G Truus Overweg-Plandsoen; Frank Baas; J Paul Taylor; Michael Benatar; Anne M Connolly; Muhammad T Al-Lozi; John Nixon; Christian G E L de Goede; A Reghan Foley; Catherine Mcwilliam; Matthew Pitt; Caroline Sewry; Rahul Phadke; Majid Hafezparast; W K Kling Chong; Eugenio Mercuri; Robert H Baloh; Mary M Reilly; Francesco Muntoni
Journal:  Neurology       Date:  2015-01-21       Impact factor: 9.910

5.  Mutations in BICD2 cause dominant congenital spinal muscular atrophy and hereditary spastic paraplegia.

Authors:  Emily C Oates; Alexander M Rossor; Majid Hafezparast; Michael Gonzalez; Fiorella Speziani; Daniel G MacArthur; Monkol Lek; Ellen Cottenie; Mariacristina Scoto; A Reghan Foley; Matthew Hurles; Henry Houlden; Linda Greensmith; Michaela Auer-Grumbach; Thomas R Pieber; Tim M Strom; Rebecca Schule; David N Herrmann; Janet E Sowden; Gyula Acsadi; Manoj P Menezes; Nigel F Clarke; Stephan Züchner; Francesco Muntoni; Kathryn N North; Mary M Reilly
Journal:  Am J Hum Genet       Date:  2013-05-09       Impact factor: 11.025

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.